Indian stocks: Visit www.stage2stocks.com →

Basel Medical Group Ltd

Stage 4 · Declining · week 19

As of Oct 22, 2026, Basel Medical Group is in Stage 4, the downtrend phase, now in week 19 (since Jun 12, 2026). It closed at $4.45, 77.7% below its 52-week high and below its 200-day average, which is falling.

Basel Medical Group Ltd provides healthcare services in Singapore. More about the company

$4.45
+1.83% today
$7.0M · Micro cap
Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is BMGL early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2025-02-25 → 2026-10-22
S? 41w
S4 22w
S4 19w
2025-02-252026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S? 41w → S4 22w → S1 4w → S4 19w current
Total tracked: 86 weeks across 4 stage runs.

BMGL among Medical Care Facilities43rd of 49 by relative strength

All 49 →
Stocks in Medical Care Facilities ranked by relative strength, with stage and one-month change
#StockStageRS1M
1AGLStage 3 · wk 898+6.8%
2PACSStage 3 · wk 498+15.7%
3LFSTStage 2 · wk 2497+4.0%
4AMNStage 2 · wk 2596+38.1%
5NHCStage 2 · wk 5995+8.4%
6CONStage 2 · wk 2294+14.9%
7INNVStage 3 · wk 593+5.8%
8MDStage 2 · wk 2692+14.3%
…43BMGLStage 4 · wk 1912+8.8%
vs 52W High
-77.7%
$3.02 lo$19.92 hi
77.7% below 52W high, deep Stage 4 damage
In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.
Stage Maturity
Week 19
1w13w26w
Week 19, established downtrend
How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.
vs 200 DMA
-32.5%
200 DMA: $6.59 · sloping down
In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.
Rel Volume
1.13x
vs 50-day avg
High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.
Trend Health
↓
Short-term trend rolling over
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
+8.8%
3M
-23.1%
6M
-40.2%
YTD
-35.1%
1Y
-77.1%
Scan Membership
Not in any current scan.
Recent Stage Timeline
2026-10-22S4
Wk 19 · Vol 1.13x
2026-10-21S4
Wk 19 · Vol 1.40x
2026-10-20S4
Wk 18 · Vol 1.62x
2026-10-19S4
Wk 18 · Vol 2.20x
2026-10-16S4
Wk 18 · Vol 1.89x
2026-10-15S4
Wk 18 · Vol 1.95x
2026-10-14S4
Wk 18 · Vol 2.27x
2026-10-13S4
Wk 17 · Vol 1.67x
2026-10-12S4
Wk 17 · Vol 0.70x
2026-10-09S4
Wk 17 · Vol 0.16x
2026-10-08S4
Wk 17 · Vol 0.19x
2026-10-07S4
Wk 17 · Vol 0.02x
Moving averages & range
50 DMA
$4.42
200 DMA
$6.59
52W High
$19.92
52W Low
$3.02
5D Low
$3.95
Resistance levels (recent highs)
20d High
$4.45
60d High
$7.14
120d High
$9.17
250d High
$19.92
Next resistance
+60.4%
to 60d High
ROE
-147.4%
Profit margin -68.2%
Dividend Yield
0.00%
P/B 1.4

Basel Medical Group: quick answers

What stage is Basel Medical Group in?

As of Oct 22, 2026, Basel Medical Group (BMGL) is in Stage 4, the downtrend phase. It entered Stage 4 on Jun 12, 2026 and is in week 19. What the four stages mean

Is Basel Medical Group in an uptrend?

No. Basel Medical Group is in a Stage 4 downtrend. It trades 32.5% below its 200-day average, which is falling.

How far is Basel Medical Group from its 52-week high?

Basel Medical Group closed at $4.45 on Oct 22, 2026, 77.7% below its 52-week high of $19.92. Its 52-week low is $3.02.

How has Basel Medical Group performed over the past year?

As of Oct 22, 2026, Basel Medical Group is down 77.1% over the past year and down 35.1% so far in 2026.

Which sector and industry is Basel Medical Group in?

Basel Medical Group is in the Medical Care Facilities industry, part of the Health Care sector.

About this companyHealth Care· Medical Care Facilities

Basel Medical Group Ltd provides healthcare services in Singapore. The company offers general and subspecialized orthopedic, including trauma and sports medicine services, such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery, and minimally invasive orthopedic procedures, as well as neurosurgical treatments. It also provides health screening services, mental health, woman's health, and general practice services. In addition, its services include consultation, medical diagnosis, and medical and surgical treatments. The company was incorporated in 2023 and is headquartered in Singapore.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.